Submitted by valerie.eijrond on Mon, 04/16/2012 - 15:53
Worldwide, more than half the people with type 2 diabetes have blood glucose concentrations that are too high, leading to a greater risk of complications. This is partly because many existing treatments have limitations.
Submitted by valerie.eijrond on Mon, 04/16/2012 - 15:44
Issues relating to people with diabetes injecting themselves with insulin quite rightly are an important focus of diabetes care. Concerns include avoiding the complications of inaccurate dosing, and ensuring the proper care of injection sites and correct use of blood glucose selfmonitoring. The current implementation of the 2010 EU Directive on sharps injury prevention, places the spotlight of attention on the safety and protection of healthcare professionals when they are administering treatment to people with diabetes. Questions arise over the risks to the diabetes specialist.
Submitted by Lorenzo.Piemonte on Fri, 12/02/2011 - 16:12
Thirty-five years on from the demonstration that type 1 diabetes has an autoimmune basis, we have learned an enormous amount about the disease. We know its genetic basis (immune genes), its pathological basis (immune cells) and we would expect to be converting this insight into therapeutic advances (immunebased). Certainly, the field of immunotherapy for type 1 diabetesis very active. Here, Mark Peakman reviews the progress being made and scans the horizon for the mostlikely future breakthroughs.
Submitted by Lorenzo.Piemonte on Fri, 12/02/2011 - 16:09
In an age of increasing global information overload, it is becoming progressively more difficult to discern real health and safety signals, or potentially beneficial possibilities, from background noise. The explosion in exploratory analyses of emerging large-scale medical record databases and registries
Submitted by Lorenzo.Piemonte on Wed, 09/14/2011 - 11:06
Nearly a century since its discovery, insulin remains beyond the reach of many people living in parts of the developing world – and access to this life-sustaining medication is problematic for many, many more. The International Insulin Foundation (IIF) was founded in 2002 to improve access to insulin in resource-poor countries.
Submitted by admin on Tue, 12/01/2009 - 14:43
Diabetic foot complications are the most common cause of hospital admissions among people with diabetes. Worldwide, more than 1 million amputations are performed each year as a consequence of diabetes, which means that a lower limb is lost to diabetes somewhere in the world every 30 seconds. If a person with diabetes has a lesion on the sole of a foot, offloading bodyweight is of vital importance; all therapeutic efforts are bound to fail if he or she continues to walk on an ulcer.
Submitted by admin on Tue, 12/01/2009 - 14:23
The good news is that most cases of severe vision loss due to diabetes are preventable; the bad news is that tens of thousands of people lose vision to diabetes each year despite all we know about prevention and treatment. Indeed, diabetes is a leading cause of vision loss around the world. Compared with the general population, people with diabetes have a 25-fold increased risk of blindness.
Submitted by admin on Thu, 10/15/2009 - 14:12
Diabetes healthcare providers are no strangers to the self-management model. Indeed, it could be said that diabetes is the field in which the self-management model has been most thoroughly developed and implemented. The marriage of expert clinical care with self-management by the individual is an ideal union and an increasingly common objective. It is an excellent goal – one that is achievable by many. Yet a number of systematic barriers to self-management exists.
Submitted by admin on Thu, 10/15/2009 - 14:00
Diabetes increases a person’s risk of developing multiple health complications. But the risk of these can be significantly reduced by close control of blood glucose. Although directly monitoring glucose levels to inform adjustments in insulin levels is now a proven part of self-management for people with type 1 diabetes, the role of glucose monitoring for people with type 2 diabetes is less well established.
Submitted by admin on Thu, 10/15/2009 - 13:55
In October 2008, the IDF Task Force on Clinical Guidelines, in conjunction with the Self-Monitoring of Blood Glucose nternational Working Group, convened a workshop in Amsterdam to address the use of self-monitoring of blood glucose (SMBG) in people with type 2 diabetes who are not treated with insulin. The recently published guidelines on the use of SMBG in people with type 2 diabetes were developed based on the findings of that workshop. A summary of the findings and recommendations is provided in this article.